Amarastesia celebrates another milestone with a written notification from the EPO on the patentability of cerA&Mvix. While filing a patent merely secures a priority date without assurances, obtaining a patent is akin to scaling Mount Everest twice within a single year. Amarastesia undoubtedly possesses robust intellectual property that supports our products and showcases a significant competitive advantage in a highly competitive market.
Comments